Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

2 results
Display

Post-marketing Surveillance Study of an Inactivated Split-Virion Influenza Vaccine in Korea

Huh JW, Ma SH, Kim HK, Gunapalaiah B, Bock HL, Fluarix-054 Study Group

  • KMID: 2278966
  • Korean J Pediatr Infect Dis.
  • 2011 Jun;18(1):68-79.
PURPOSE: This post-marketing surveillance study (NCT00750360) assessed the safety and reactogenicity of an inactivated, trivalent split-virion influenza vaccine licensed for use in the Korea since 2002. METHODS: Eight hundred and eighty...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Human papillomavirus 16/18 AS04-adjuvanted cervical cancer vaccine: immunogenicity and safety in 15-25 years old healthy Korean women

Kim SC, Song YS, Kim YT, Kim YT, Ryu KS, Gunapalaiah B, Bi D, Bock HL, Park JS

OBJECTIVE: The study assessed the immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in healthy Korean women aged 15-25 years. METHODS: Phase IIIB, double-blind, randomised (2:1), multi-centre trial...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr